Genetic regulation of skeletal patterning, differentiation, and growth

Bone

Volumn 25, Issue 1, 1999, Pages 77-79

  Olsen, B R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 10;

ANIMAL CELL; ANIMAL TISSUE; BONE DEVELOPMENT; BONE DISEASE; BONE GROWTH; CARTILAGE CELL; CHONDRODYSPLASIA; DYSOSTOSIS; GENE MUTATION; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME; MORPHOGENESIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PHENOTYPE; POLYDACTYLY; SHORT SURVEY; SKELETON; SKELETON MALFORMATION; SYNDACTYLY; TISSUE DIFFERENTIATION; TRANSGENIC MOUSE;

EID: 0033041097     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00114-3     Document Type: Article

References (24)

1. Bucay N., Sarosi I., Dunstan C.R., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12:1998;1260-1268.
2. Chan D., Jacenko O. Phenotypic and biochemical consequences of collagen X mutations in mice and humans. Matrix Biol. 17:1998;169-184.
3. Chan D., Weng Y.M., Graham H.K., Sillence D.O., Bateman J.F. A nonsense mutation in the carboxyl-terminal domain of type X collagen causes haploinsufficiency in schmid metaphyseal chondrodysplasia. J Clin Invest. 101:1998;1490-1499.
4. Chan D., Weng Y.M., Hocking A.M., Golub S., McQuillan D.J., Bateman J.F. Site-directed mutagenesis of human type X collagen Expression of alpha1(X) NC1, NC2, and helical mutations in vitro and in transfected cells . J Biol Chem. 271:1996;13566-13572.
5. Dolle P., Dierich A., LeMeur M., Schimmang T., Schuhbaur B., Chambon P., Duboule D. Disruption of the Hoxd-13 gene induces localized heterochrony leading to mice with neotenic limbs. Cell. 75:1993;431-441.
6. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1 a transcriptional activator of osteoblast differentiation . Cell. 89:1997;747-754.
7. Goodman F., Giovannucci-Uzielli M.-L., Hall C., Reardon W., Winter R., Scambler P. Deletions in HOXD13 segregate with an identical, novel foot malformation in two unrelated families. Am J Hum Genet. 63:1998;992-1000.
8. Goodman F.R., Munclos S., Muragaki Y., et al. Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract. Proc Natl Acad Sci USA. 94:1997;7458-7463.
9. Huang L.F., Fukai N., Selby P.B., Olsen B.R., Mundlos S. Mouse clavicular development analysis of wild-type and cleidocranial dysplasia mutant mice . Dev Dyn. 210:1997;33-40.
10. Ikegawa S., Nakamura K., Nagano A., Haga N., Nakamura Y. Mutations in the N-terminal globular domain of the type X collagen gene (COL10A1) in patients with schmid metaphyseal chondrodysplasia. Hum Mutat. 9:1997;131-135.
11. Jacenko O., LuValle P.A., Olsen B.R. Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition. Nature. 365:1993;56-61.
12. Johnson K.R., Sweet H.O., Donahue L.R., Ward-Bailey P., Bronson R.T., Davisson M.T. A new spontaneous mouse mutation of Hoxd13 with a polyalanine expansion and phenotype similar to human synpolydactyly. Hum Mol Genet. 7:1998;1033-1038.
13. Jones W.A. Cherubism A thumbnail sketch of its diagnosis and a conservative . Oral Surg Oral Med Oral Pathol. 20:1965;648-653.
14. Komori T., Yagi H., Nomura S., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:1997;755-764.
15. Kwan K.M., Pang M.K., Zhou S., et al. Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X implications for function . J Cell Biol. 136:1997;459-471.
16. Lacey D.L., Timms E., Tan H.L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165-176.
17. Martin T.J., Roams E., Gillespie M.T. Interleukins in the control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr. 8:1998;107-123.
18. Mundlos S., Otto F., Mundlos C., et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 89:1997;773-779.
19. Muragaki Y., Mundlos S., Upton J., Olsen B.R. Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science. 272:1996;548-551.
20. Otto F., Thornell A.P., Crompton T., et al. CBFA1, a candidate gene for the cleidocranial dysplasia syndrome, is essential for osteoblast formation and bone development. Cell. 89:1997;765-771.
21. Simonet W.S., Lacey D.L., Dunstan C.R., et al. Osteoprotegerin a novel secreted protein involved in the regulation of bone density . Cell. 89:1997;309-319.
22. Warman M.L., Abbott M.H., Apte S.S., et al. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nature Genetics. 5:1993;79-82.
23. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 95:1998;3597-3602.
24. Zakany J., Duboule D. Synpolydactyly in mice with a targeted deficiency in the HoxD complex. Nature. 384:1996;69-71.